Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+16.58%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$84.1B
AUM Growth
+$9.18B
(+12%)
Cap. Flow
-$227M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
33.22%
Holding
3,151
New
699
Increased
893
Reduced
848
Closed
646
Top Buys
| 1 |
CRCL
Circle Internet Group, Inc.
CRCL
|
+$1.55B |
| 2 |
NVIDIA
NVDA
|
+$1.14B |
| 3 |
Amazon
AMZN
|
+$488M |
| 4 |
T-Mobile US
TMUS
|
+$421M |
| 5 |
Eli Lilly
LLY
|
+$399M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.41B |
| 2 |
Tesla
TSLA
|
+$928M |
| 3 |
Danaher
DHR
|
+$545M |
| 4 |
Intuit
INTU
|
+$543M |
| 5 |
Meta Platforms (Facebook)
META
|
+$464M |
Sector Composition
| 1 | Technology | 21.23% |
| 2 | Consumer Discretionary | 14.33% |
| 3 | Healthcare | 10.99% |
| 4 | Financials | 9.07% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Inogen
INGN
$223M
| $184K | ﹤0.01% |
26,181
-16,004
| -38% | -$113K |
|
2302
Taysha Gene Therapies
TSHA
$876M
| $184K | ﹤0.01% |
+79,498
| New | +$184K |
|
2303
US Gold Corp
USAU
$189M
| $183K | ﹤0.01% |
15,028
+287
| +2% | +$3.5K |
|
2304
Neumora Therapeutics
NMRA
$269M
| $183K | ﹤0.01% |
+250,490
| New | +$183K |
|
|
LADR
2305
Ladder Capital
LADR
$1.49B
| $183K | ﹤0.01% |
+17,005
| New | +$183K |
|
2306
Y-mAbs Therapeutics
YMAB
$390M
| $181K | ﹤0.01% |
+40,181
| New | +$181K |
|
2307
Five Point Holdings
FPH
$414M
| $181K | ﹤0.01% |
32,834
-15,314
| -32% | -$84.2K |
|
2308
Relay Therapeutics
RLAY
$672M
| $179K | ﹤0.01% |
+51,698
| New | +$179K |
|
2309
Leslie's
LESL
$62M
| $177K | ﹤0.01% |
421,280
+370,680
| +733% | +$156K |
|
2310
Gencor Industries
GENC
$229M
| $176K | ﹤0.01% |
12,540
-13,764
| -52% | -$193K |
|
2311
LiveOne
LVO
$58.6M
| $174K | ﹤0.01% |
+231,435
| New | +$174K |
|
2312
Grupo Aval
AVAL
$3.99B
| $171K | ﹤0.01% |
60,733
+25,753
| +74% | +$72.4K |
|
2313
Evotec
EVO
$1.23B
| $169K | ﹤0.01% |
+40,310
| New | +$169K |
|
|
USAS
2314
Americas Gold and Silver
USAS
$747M
| $169K | ﹤0.01% |
83,440
-194,164
| -70% | -$393K |
|
2315
Sutro Biopharma
STRO
$83.4M
| $166K | ﹤0.01% |
+234,431
| New | +$166K |
|
|
CLPR
2316
Clipper Realty
CLPR
$70.7M
| $165K | ﹤0.01% |
44,987
+1,269
| +3% | +$4.66K |
|
2317
AbCellera Biologics
ABCL
$1.27B
| $163K | ﹤0.01% |
47,480
| – | – |
|
2318
Pyxis Oncology
PYXS
$114M
| $163K | ﹤0.01% |
+147,771
| New | +$163K |
|
2319
Digimarc
DMRC
$203M
| $162K | ﹤0.01% |
12,276
-101,974
| -89% | -$1.35M |
|
|
QIPT
2320
Quipt Home Medical
QIPT
$113M
| $162K | ﹤0.01% |
+90,514
| New | +$162K |
|
2321
Wave Life Sciences
WVE
$1.18B
| $161K | ﹤0.01% |
+24,828
| New | +$161K |
|
2322
Mammoth Energy Services
TUSK
$112M
| $161K | ﹤0.01% |
+57,436
| New | +$161K |
|
2323
Lufax Holding
LU
$2.58B
| $160K | ﹤0.01% |
+57,404
| New | +$160K |
|
2324
Acumen Pharmaceuticals
ABOS
$84.8M
| $160K | ﹤0.01% |
+137,943
| New | +$160K |
|
2325
Invivyd
IVVD
$289M
| $158K | ﹤0.01% |
+222,633
| New | +$158K |
|